Wird geladen...
Parathyroid Hormone Mediates Bone Growth through the Regulation of Osteoblast Proliferation and Differentiation
PTH (1–34) is the only FDA-approved anabolic agent for osteoporosis treatment in the U.S., but its mechanisms are not completely understood. This study investigated PTH effects on osteogenic cells at various stages of differentiation and proliferation using an engineered bone growth model in vivo. O...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2007
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2677418/ https://ncbi.nlm.nih.gov/pubmed/18234576 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bone.2007.11.017 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|